ArticleInternational journal of surgery (London, England)2026
Normal weight obesity and the risk of liver cancer in 0.3 million Chinese adults: a prospective multicenter cohort study.
Article in International journal of surgery (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Normal weight, hidden risk: adiposity is a better determinant of liver cancer than body mass index.Hepatobiliary surgery and nutrition · 2026Article
Corrections and comments
- Commented on by
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundObesity has been found to be an independent risk factor for liver cancer. However, whether normal-weight obesity (NWO), defined as a normal body mass index (BMI) but high body fat content, is associated with an increased risk of this cancer remains unknown. We performed a prospective multicenter cohort study to examine the potential association of NWO with the risk of liver cancer in a nationally representative Chinese population. MATERIALS AND
methodsA total of 319 781 Chinese adults with a normal BMI (18.5-24.9 kg/m 2 ) were included and followed up through 31 December 2018. Participants in the highest sex-specific tertile of body fat percentage were classified into NWO group. Cox regression was used to calculate hazard ratio for liver cancer incidence. Subgroup analyses were conducted to identify the potential effect modifiers.
resultsDuring an average follow-up of 11.75 years, 1495 liver cancer cases occurred. In the fully adjusted model, NWO was found to be associated with an elevated risk of liver cancer (hazard ratio 1.22, 95% confidence interval 1.07-1.39), which remained in both propensity-score-adjusted and -matched analyses. Subgroup analysis revealed a stronger positive association in HBsAg-negative participants than in those with HBsAg positivity ( Pinteraction = 0.008). Body fat percentage was found to be positively associated with the risk of liver cancer in a nonlinear dose-response manner ( Pnonlinearity < 0.001). No significant joint association of central obesity and NWO with the risk of liver cancer was found ( Padditive interaction = 0.298). Similar results were obtained when the above analyses were performed in men and women separately.
conclusionsNWO confers an increased risk of liver cancer in this Chinese population. Our findings suggest that body fat loss may be beneficial in reducing liver cancer risk in individuals with a normal BMI, and highlight that the traditional BMI categorization may be inadequate in risk stratification of this cancer.
Indexed as
Identifiers
41489343What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.